BioWorld Asia

Nov. 9, 2005

ExonHit Launches 6.5M IPO On Alternext Market

PARIS - ExonHit Therapeutics SA launched an initial public offering on the Alternext market of the Euronext stock exchange in Paris Nov. 8, hoping to raise 6.5 million (US$7.6 million). (BioWorld International) Read More

Raising Drug Prices In Europe Suggested As Solution For U.S.

Molecular Mimic Could Lead To New Immunotherapeutics

DOR Buying Gastrotech For $39M In Shares, Milestones

Fovea Brings In $25M For Retinal Disease Research

Ariana Signs With Pasteur Institute, Picks Up Funding

Vernalis Paying Mylan $23M For U.S. Rights To Apokyn

Other News To Note

Today's news in brief

BioWorld

BioWorld briefs for Dec. 27, 2024.

Today's news in brief

BioWorld MedTech

BioWorld MedTech briefs for December 24, 2024.

Illustration of neurons with Lewy bodies

Enhanced Cognition: Lewy body dementia phase II pumps stock

BioWorld

Investors will get more details during the International Lewy Body Dementia Conference in Amsterdam late next month, but Wall Street is already buzzing about...

Experimental mRNA gene therapy suppresses preeclampsia in mice

BioWorld MedTech

A gene therapy based on an enhanced lipid nanoparticle (LNP) loaded with vascular endothelial growth factor (VEGF) mRNA could be developed for the treatment of...

Lab glassware and antibodies art concept

Probing bidirectional cancer-autoimmune link can yield new targets

BioWorld Science

Cancer and autoimmunity are “often thought of as being at opposite ends of the immune response,” Ana Anderson told her audience at a joint meeting of the NIH’s...